Pullen Investment Management LLC Sells 52,463 Shares of Kenvue Inc. $KVUE

by · The Cerbat Gem

Pullen Investment Management LLC lessened its stake in Kenvue Inc. (NYSE:KVUE – Free Report) by 61.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,298 shares of the company’s stock after selling 52,463 shares during the quarter. Pullen Investment Management LLC’s holdings in Kenvue were worth $574,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Salomon & Ludwin LLC purchased a new position in Kenvue during the third quarter valued at $25,000. NBT Bank N A NY increased its holdings in Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares during the last quarter. Cornerstone Planning Group LLC lifted its stake in Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after purchasing an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont boosted its holdings in shares of Kenvue by 50.9% during the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on KVUE shares. UBS Group lifted their target price on Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Argus raised Kenvue to a “hold” rating in a research note on Friday, March 6th. Canaccord Genuity Group raised their price target on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $23.00 to $18.00 in a research note on Friday, January 30th. Finally, Citigroup upped their price objective on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $19.58.

Check Out Our Latest Stock Report on Kenvue

Kenvue Price Performance

KVUE stock opened at $17.16 on Friday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The firm has a market capitalization of $32.90 billion, a P/E ratio of 22.29, a price-to-earnings-growth ratio of 3.89 and a beta of 0.61. The company has a fifty day simple moving average of $17.98 and a two-hundred day simple moving average of $17.08. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE – Get Free Report) last posted its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.68 billion. During the same period in the previous year, the firm posted $0.26 EPS. The business’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue’s payout ratio is presently 107.79%.

About Kenvue

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Featured Stories

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).